1370 related articles for article (PubMed ID: 28270698)
1. Gut microbiota modulation of chemotherapy efficacy and toxicity.
Alexander JL; Wilson ID; Teare J; Marchesi JR; Nicholson JK; Kinross JM
Nat Rev Gastroenterol Hepatol; 2017 Jun; 14(6):356-365. PubMed ID: 28270698
[TBL] [Abstract][Full Text] [Related]
2. Gut microbiota and cancer: How gut microbiota modulates activity, efficacy and toxicity of antitumoral therapy.
Gori S; Inno A; Belluomini L; Bocus P; Bisoffi Z; Russo A; Arcaro G
Crit Rev Oncol Hematol; 2019 Nov; 143():139-147. PubMed ID: 31634731
[TBL] [Abstract][Full Text] [Related]
3. Gut Microbiota Modulation of Efficacy and Toxicity of Cancer Chemotherapy and Immunotherapy.
Chrysostomou D; Roberts LA; Marchesi JR; Kinross JM
Gastroenterology; 2023 Feb; 164(2):198-213. PubMed ID: 36309208
[TBL] [Abstract][Full Text] [Related]
4. The intimate relationship between gut microbiota and cancer immunotherapy.
Elkrief A; Derosa L; Zitvogel L; Kroemer G; Routy B
Gut Microbes; 2019; 10(3):424-428. PubMed ID: 30339501
[TBL] [Abstract][Full Text] [Related]
5. Pharmacomicrobiomics: exploiting the drug-microbiota interactions in anticancer therapies.
Panebianco C; Andriulli A; Pazienza V
Microbiome; 2018 May; 6(1):92. PubMed ID: 29789015
[TBL] [Abstract][Full Text] [Related]
6. The influence of gut microbiota dysbiosis to the efficacy of 5-Fluorouracil treatment on colorectal cancer.
Yuan L; Zhang S; Li H; Yang F; Mushtaq N; Ullah S; Shi Y; An C; Xu J
Biomed Pharmacother; 2018 Dec; 108():184-193. PubMed ID: 30219675
[TBL] [Abstract][Full Text] [Related]
7. Gut Microbiota Shapes the Efficiency of Cancer Therapy.
Ma W; Mao Q; Xia W; Dong G; Yu C; Jiang F
Front Microbiol; 2019; 10():1050. PubMed ID: 31293523
[TBL] [Abstract][Full Text] [Related]
8. Contribution of Aging, Obesity, and Microbiota on Tumor Immunotherapy Efficacy and Toxicity.
Baiden-Amissah REM; Tuyaerts S
Int J Mol Sci; 2019 Jul; 20(14):. PubMed ID: 31340438
[TBL] [Abstract][Full Text] [Related]
9. Emerging role of microbiota in immunomodulation and cancer immunotherapy.
Singh RP; Bashir H; Kumar R
Semin Cancer Biol; 2021 May; 70():37-52. PubMed ID: 32580024
[TBL] [Abstract][Full Text] [Related]
10. Toll-like receptors in the pathogenesis of chemotherapy-induced gastrointestinal toxicity.
Cario E
Curr Opin Support Palliat Care; 2016 Jun; 10(2):157-64. PubMed ID: 26986508
[TBL] [Abstract][Full Text] [Related]
11. The gut microbiota and immune checkpoint inhibitors.
Humphries A; Daud A
Hum Vaccin Immunother; 2018; 14(9):2178-2182. PubMed ID: 29494275
[TBL] [Abstract][Full Text] [Related]
12. The impact of modulating the gastrointestinal microbiota in cancer patients.
Morkūnas E; Skiecevičienė J; Kupčinskas J
Best Pract Res Clin Gastroenterol; 2020; 48-49():101700. PubMed ID: 33317795
[TBL] [Abstract][Full Text] [Related]
13. Probiotics, prebiotics and colorectal cancer prevention.
Ambalam P; Raman M; Purama RK; Doble M
Best Pract Res Clin Gastroenterol; 2016 Feb; 30(1):119-31. PubMed ID: 27048903
[TBL] [Abstract][Full Text] [Related]
14. [Gut microbiota and efficacy of cancer therapies].
Vétizou M; Daillère R; Zitvogel L
Biol Aujourdhui; 2017; 211(1):51-67. PubMed ID: 28682227
[TBL] [Abstract][Full Text] [Related]
15. Gut microbiota role in irritable bowel syndrome: New therapeutic strategies.
Distrutti E; Monaldi L; Ricci P; Fiorucci S
World J Gastroenterol; 2016 Feb; 22(7):2219-41. PubMed ID: 26900286
[TBL] [Abstract][Full Text] [Related]
16. [Gut microbiota: What impact on colorectal carcinogenesis and treatment?].
Bruneau A; Baylatry MT; Joly AC; Sokol H
Bull Cancer; 2018 Jan; 105(1):70-80. PubMed ID: 29217301
[TBL] [Abstract][Full Text] [Related]
17. The involvement of gut microbiota in inflammatory bowel disease pathogenesis: potential for therapy.
Cammarota G; Ianiro G; Cianci R; Bibbò S; Gasbarrini A; Currò D
Pharmacol Ther; 2015 May; 149():191-212. PubMed ID: 25561343
[TBL] [Abstract][Full Text] [Related]
18. Role of the normal gut microbiota.
Jandhyala SM; Talukdar R; Subramanyam C; Vuyyuru H; Sasikala M; Nageshwar Reddy D
World J Gastroenterol; 2015 Aug; 21(29):8787-803. PubMed ID: 26269668
[TBL] [Abstract][Full Text] [Related]
19. Association Between Gut Microbiota and Bone Health: Potential Mechanisms and Prospective.
Chen YC; Greenbaum J; Shen H; Deng HW
J Clin Endocrinol Metab; 2017 Oct; 102(10):3635-3646. PubMed ID: 28973392
[TBL] [Abstract][Full Text] [Related]
20. Immunomodulatory effect of fibres, probiotics and synbiotics in different life-stages.
Romeo J; Nova E; Wärnberg J; Gómez-Martínez S; Díaz Ligia LE; Marcos A
Nutr Hosp; 2010; 25(3):341-9. PubMed ID: 20593114
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]